Be among trailblazing marketing pros at Brandweek this September 23–26 in Phoenix, Arizona. Experience incredible networking, insightful sessions and a boost of inspiration at ADWEEK’s ultimate brand event. Register by May 13 to save 35%.
With the recall of Vioxx and other medications amid concerns about side effects, you might think people would be more wary of direct-to-consumer (DTC) ads that promote such drugs. After all, Americans seemed eager to think ill of the pharmaceutical industry even when they thought its products worked just fine. However, a survey by Ipsos PharmTrends finds no dramatic downturn in the effectiveness of DTC advertising. Rather, it documents a continuation of what was already a gradual decline in the impact of such ads.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in